Risk and prognosis factors for systemic sclerosis with lung cancer: A single‐centre case‐control study in China-Reference-Cited by-同舟云学术

Risk and prognosis factors for systemic sclerosis with lung cancer: A single‐centre case‐control study in China

Published:2020-11-20 Issue:4 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Zhong Hui¹^ORCID,Zhou Jiaxin¹,Zhang Shangzhu¹,Xu Yan²,Hou Yong¹,Li Mengtao¹,Xu Dong¹,Wang Mengzhao²,Zeng Xiaofeng¹

Affiliation:

1. Department of Rheumatology and Clinical Immunology of Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education Beijing China

2. Department of Respiratory and Critical Care Medicine of Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13819

Reference28 articles.

1. Changes in causes of death in systemic sclerosis, 1972-2002

2. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

3. Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study

4. Risk of malignancy in scleroderma: A population-based cohort study

5. Risk of cancer in patients with scleroderma: a population based cohort study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Sclerosis Association with Malignancy;Clinical Reviews in Allergy & Immunology;2022-09-19